You are here

A Safe Analgesic Drug with Addiction Treatment Potential

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43DA016032-01A1
Agency Tracking Number: DA016032
Amount: $100,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Timeline
Solicitation Year: 2004
Award Year: 2004
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
PHOENIX PHARMALABS, INC. 941 W 600S, #1
LOGAN, UT 84321
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 JOHN Lawson
 (435) 750-6500
 JALAWSON3@COMCAST.NET
Business Contact
 JOHN LAWSON
Phone: (435) 792-3001
Email: JALAWSON3@ATTBI.COM
Research Institution
N/A
Abstract

DESCRIPTION (provided by applicant): This SBIR grant is sought for the purpose of commercializing a promising and needed drug NIH 10497(D-1). It is a novel, orally active opioid with a unique chiral N-substituent that confers an unprecedented activity pr

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government